The statistic shows the number of companies in the medical technology and pharmaceutical sectors in Australia as of 2017. There were nearly one thousand companies in total, of which around 500 were in the medical technology sector alone.
Number of companies in Australia's medtech and pharma sectors as of 2017
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Pharmaceutical research and development
Overview
6
- Premium Statistic Total global pharmaceutical R&D spending 2014-2028
- Premium Statistic R&D spending growth worldwide on pharmaceuticals 2015-2028
- Premium Statistic Growth rate of R&D spending in pharmaceutical industry by major region 2007-2022
- Premium Statistic Number of drugs in the R&D pipeline worldwide 2001-2024
- Basic Statistic Pharma companies worldwide with active R&D pipelines 2001-2024
- Basic Statistic Projected most valuable R&D projects based on net present value 2023
R&D performance by company
5
- Premium Statistic R&D spending share of top pharmaceutical companies 2022
- Basic Statistic Top pharmaceutical companies in R&D spending growth 2022
- Basic Statistic Top 50 global pharmaceutical and biotech companies by R&D intensity in 2022
- Premium Statistic Top pharma companies worldwide 2024, by size of R&D pipeline
- Premium Statistic Distribution of pharmaceutical R&D companies by region 2023 vs. 2024
Characteristics of R&D pipeline
5
- Basic Statistic Top therapeutic categories worldwide 2024, by number of R&D products
- Premium Statistic Worldwide top diseases 2024, by number of active drugs
- Basic Statistic Worldwide top origins for pipeline drugs by number of active drugs 2024
- Basic Statistic Worldwide pipeline drugs by delivery route share 2023 vs. 2024
- Basic Statistic Worldwide top drug producing mechanisms of action by number of active compounds 2024
Duration, cost and ROI
4
- Basic Statistic Average length of a clinical trial cycle 2014-2022
- Basic Statistic Rate of return on biopharma R&D late stage pipeline 2013-2023
- Premium Statistic Average R&D cost to develop new biopharma compound 2013-2023
- Premium Statistic Average peak sales forecast per new biopharmaceutical asset 2013-2023
Outsourced R&D
4
Public opinion/knowledge
6
- Basic Statistic Willingness to pay more taxes for additional medical research - U.S. adults 2019-2023
- Basic Statistic View of health research as a problem or solution for rising costs - U.S. adults 2020
- Basic Statistic Importance to support private investments in medical research by government 2022
- Premium Statistic U.S. approval of pharma companies' COVID-19 vaccine development handling 2021
- Basic Statistic Share of U.S. adults who could name a medical or health research entity 2024
- Basic Statistic Participation in clinical trials recommended by a doctor among U.S. adults 2021
Further related statistics
10
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Johnson & Johnson's number of employees 2004-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Revenue of Sinopharm 2011-2022, by category
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
Further Content: You might find this interesting as well
Statistics
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Johnson & Johnson's number of employees 2004-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Revenue of Sinopharm 2011-2022, by category
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
CSIRO. (April 18, 2017). Number of companies in Australia's medtech and pharma sectors as of 2017 [Graph]. In Statista. Retrieved June 14, 2024, from https://www.statista.com/statistics/717076/company-number-in-australian-medtech-and-pharma-sectors/
CSIRO. "Number of companies in Australia's medtech and pharma sectors as of 2017." Chart. April 18, 2017. Statista. Accessed June 14, 2024. https://www.statista.com/statistics/717076/company-number-in-australian-medtech-and-pharma-sectors/
CSIRO. (2017). Number of companies in Australia's medtech and pharma sectors as of 2017. Statista. Statista Inc.. Accessed: June 14, 2024. https://www.statista.com/statistics/717076/company-number-in-australian-medtech-and-pharma-sectors/
CSIRO. "Number of Companies in Australia's Medtech and Pharma Sectors as of 2017." Statista, Statista Inc., 18 Apr 2017, https://www.statista.com/statistics/717076/company-number-in-australian-medtech-and-pharma-sectors/
CSIRO, Number of companies in Australia's medtech and pharma sectors as of 2017 Statista, https://www.statista.com/statistics/717076/company-number-in-australian-medtech-and-pharma-sectors/ (last visited June 14, 2024)
Number of companies in Australia's medtech and pharma sectors as of 2017 [Graph], CSIRO, April 18, 2017. [Online]. Available: https://www.statista.com/statistics/717076/company-number-in-australian-medtech-and-pharma-sectors/